A5040328245- Cancer Mechanisms and Therapy
- Colorectal Cancer Treatments and Studies
- Cancer Research and Treatments
- Cancer Immunotherapy and Biomarkers
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastric Cancer Management and Outcomes
- Glycosylation and Glycoproteins Research
- Peptidase Inhibition and Analysis
- Angiogenesis and VEGF in Cancer
- Platelet Disorders and Treatments
Sichuan University
2021-2022
West China Hospital of Sichuan University
2022
Primary adenosquamous carcinoma (ASC) is a rare liver malignancy with very little data published so far. We describe the clinical characteristics of this tumor and analyze its survival pattern to improve diagnosis treatment.This study collected 15 patients primary hepatic ASC in our hospital within 10 years (from 2009 2018). analyzed characteristics, imaging data, treatment, study. Two these cases have been reported.The common symptoms are pain jaundice. Laboratory examination showed that...
Gastric cancer is the second most prevalent and leading cause of cancer-related death in China. The prognosis metastatic gastric poor with a median overall survival 8-10 months. Apatinib, an oral small-molecule, selective vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor, approved as third-line or subsequent therapy for Several recent small-scale studies case reports showed that it may be great help improvement second-line treatment patients advanced cancer. Here, we...